Blackstone to invest up to $250 million in Autolus Therapeutics of U.K.
Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said.
Merck COVID-19 pill sparks calls for access for lower income countries
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.
Bill & Melinda Gates Foundation gives Dare Bioscience a boost
Shares of Daré Bioscience, Inc., surged 63% ahead of Wednesday's opening bell after the biotech company reported a nearly $49 million grant from The Bill & Melinda Gates Foundation.
Coronavirus tests: which one should you take?
Trump orders new coronavirus tests, who will get them first?
When a coronavirus vaccine might be ready
Dr. Weiner says this is the fastest a vaccine has been advanced to the clinic in history
Prototype bionic leg could revolutionize prosthetics
Engineers at the Bionic Engineering Lab at the University of Utah are creating new tech that may make traditional prosthetics a thing of the past.
Can coffee cause cancer?
The link between coffee and cancer
Girl's HIV infection seems under control without AIDS drugs
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines.
Correction: Global Cyberattack story
Britain's National Cyber Security Center says teams are working "round the clock" to restore hospital computer systems after a global cyberattack that hit dozens of countries forced British hospitals to cancel and delay treatment for patients.
World cyberattack cripples UK hospitals, demands ransoms
Several British hospitals say they are having major computer problems as the result of an apparent cyberattack.